Status:
UNKNOWN
Glutamatergic Amino Acids and Oxytocin Levels in the Plasma of Patients in First Psychotic Episode (FPE)- Before and After Neuroleptic Treatment
Lead Sponsor:
Shalvata Mental Health Center
Conditions:
Schizophrenia
Schizophreniform
Eligibility:
All Genders
18-60 years
Brief Summary
The goal of our research is to check the levels of D-Serine, Glycine, and other Glutamatergic amino acids, in patients with First Psychotic Episode (FPE). These patients are in the early stage of the ...
Eligibility Criteria
Inclusion
- Subjects between 18-60 years
- Clinical Diagnosis of Schizophrenia, Schizophreniphorm disorder, Schizoaffective Disorder, Brief esychotic episode
Exclusion
- two years or more of positive symptoms
- Neuroleptic treatment for more then twe weeks in the prior month, or for more then six weeks at any time.
- Drug induced psychotic episode
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00789022
Start Date
January 1 2009
Last Update
November 11 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shalvata Medical Center
Hod Hasharom, Israel